hotspot -WSS

hotspot

author：comprehensive 2025-09-30 08:45:55 - browse：2

David Sabatini at home — David Sabatini posed at his home in Cambridge in 2022. Craig F. Walker/Boston Globe

Former MIT and Whitehead Institute star biologist David Sabatini, who lost his lofty positions after being accused of violating sexual harassment policies in 2021, is rejoining the Boston scientific community as head of a research group at a new laboratory under the umbrella of a Czech-based scientific institute.

Sabatini, who has denied harassing anyone and filed litigation over the claims, has been working since last October in a senior research position at the Institute of Organic Chemistry and Biochemistry, in the Czech Republic capital of Prague, investigating scientific questions in the areas of cell growth and metabolism, similar to his past research at Whitehead.

The Czech institute, known as IOCB Prague, is realizing a long-held ambition to expand into the Boston biotech hub, confirmed the institute’s director, Jan Konvalinka.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare details structure of new drug price negotiation program
Next article： An exit interview with Bristol Myers Squibb CEO Giovanni Caforio

WSS

Chimpanzees, like humans and whales, get menopause: Study

Can we make enough H5N1 bird flu vaccine if there's a pandemic?

Microsoft's Peter Lee says ChatGPT shouldn't be used for initial diagnosis

Wellcome Trust’s new CEO hopes Big Tech gets more involved in public health

It's time to retire 'poor historian' from clinicians' vocabularies

The pink breast cancer awareness ribbon needs a redesign

knowledge

hotspot

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

focus

Novavax promises a turnaround & Lilly roils the obesity market

Traditional Chinese medicine benefits explored in new JAMA study

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Case highlights the risks of experimental stem cell therapy

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Testing for cancer recurrence creates a new limbo for patients

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Cassava reveals details — and problems — with Alzheimer's study

As demand for Covid shots wanes, Moderna seeks its next success

Venture capitalist Bob Kocher on the state of digital health

leisure time

Military medical care influenced by rank and race, new study finds

Readers respond to H5N1 and livestock movements, and more

Telehealth options flood the market as retailers push virtual care

Meta's Zuckerberg and Chan on track to put $50 billion into science

Readout Newsletter: XBI biotech index, Akero Therapeutics

Eli Lilly to pay $200M for Beam’s stake in gene

explore

leisure time

focus

explore